Guest: Stephane Bancel CEO of Moderna
In this episode Nicolai Tangen talks to Stephane Bancel, CEO of Moderna. They discuss vaccine rollouts, China’s zero-COVID-19 policy, ethical dilemmas in the pharma industry and much more.
In this episode Nicolai Tangen talks to Stephane Bancel, CEO of Moderna. They discuss vaccine rollouts, China’s zero-COVID-19 policy, ethical dilemmas in the pharma industry and much more.
At end of 2021 the fund's holdings in Moderna had a market value of 6.6 billion kroner or 753 million dollar.
The production team on this episode were Plan B's Tor-Erik Humlen and Olav Haraldsen Roen. Background research were done by Sigurd Brekke and Bård Ove Molberg with additional input from our portfolio manager Mark Dainty.